These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12650947)

  • 1. The pharmacology of putative early-onset antidepressant strategies.
    Blier P
    Eur Neuropsychopharmacol; 2003 Mar; 13(2):57-66. PubMed ID: 12650947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin and Norepinephrine Reuptake Inhibitors.
    Shelton RC
    Handb Exp Pharmacol; 2019; 250():145-180. PubMed ID: 30838456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing antidepressant treatment: efficacy and tolerability.
    Deakin B; Dursun S
    Int Clin Psychopharmacol; 2002 Jun; 17 Suppl 1():S13-24. PubMed ID: 12369607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanism of action of antidepressants and therapeutic perspectives].
    Bourin M; David DJ; Jolliet P; Gardier A
    Therapie; 2002; 57(4):385-96. PubMed ID: 12422559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoamine neurocircuitry in depression and strategies for new treatments.
    Hamon M; Blier P
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New developments in the treatment of depression.
    Montgomery SA
    J Clin Psychiatry; 1999; 60 Suppl 14():10-5; discussion 31-5. PubMed ID: 10408420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression.
    Blier P; de Montigny C; Chaput Y
    J Clin Psychopharmacol; 1987 Dec; 7(6 Suppl):24S-35S. PubMed ID: 3323264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mirtazapine: a review of its use in major depression.
    Holm KJ; Markham A
    Drugs; 1999 Apr; 57(4):607-31. PubMed ID: 10235695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can we increase speed and efficacy of antidepressant treatments? Part I: General aspects and monoamine-based strategies.
    Artigas F; Bortolozzi A; Celada P
    Eur Neuropsychopharmacol; 2018 Apr; 28(4):445-456. PubMed ID: 29174531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How does pindolol improve antidepressant action?
    Artigas F; Celada P; Laruelle M; Adell A
    Trends Pharmacol Sci; 2001 May; 22(5):224-8. PubMed ID: 11339972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin noradrenaline reuptake inhibitors: Logical evolution of antidepressant development.
    Montgomery S
    Int J Psychiatry Clin Pract; 2006; 10 Suppl 2():5-11. PubMed ID: 24921676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanism of action of new generation antidepressants under development in Japan: focusing on dopamine neurotransmission].
    Nakayama K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Jun; 29(3):99-108. PubMed ID: 19663259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of presynaptic alpha2-adrenoceptors in antidepressant action: recent findings from microdialysis studies.
    Invernizzi RW; Garattini S
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Aug; 28(5):819-27. PubMed ID: 15363606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developments in the field of antidepressants, where do we go now?
    Artigas F
    Eur Neuropsychopharmacol; 2015 May; 25(5):657-70. PubMed ID: 23706576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity and onset of action of reboxetine and effect of combination with sertraline in an animal model of depression.
    Harkin A; Kelly JP; McNamara M; Connor TJ; Dredge K; Redmond A; Leonard BE
    Eur J Pharmacol; 1999 Jan; 364(2-3):123-32. PubMed ID: 9932714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining pindolol and paroxetine in an animal model of chronic antidepressant action--can early onset of action be detected?
    Cryan JF; McGrath C; Leonard BE; Norman TR
    Eur J Pharmacol; 1998 Jul; 352(1):23-8. PubMed ID: 9718263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neurobiology and pharmacology of depression. A comparative overview of serotonin selective antidepressants.
    Harvey BH
    S Afr Med J; 1997 Apr; 87(4 Suppl):540-50, 552. PubMed ID: 9180828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noradrenergic antidepressants increase cortical dopamine: potential use in augmentation strategies.
    Masana M; Castañé A; Santana N; Bortolozzi A; Artigas F
    Neuropharmacology; 2012 Sep; 63(4):675-84. PubMed ID: 22652058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mirtazapine : A Review of its Pharmacology and Therapeutic Potential in the Management of Major Depression.
    Davis R; Wilde MI
    CNS Drugs; 1996 May; 5(5):389-402. PubMed ID: 26071050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.